(VIANEWS) – The NASDAQ ended the session with Arcturus Therapeutics (ARCT) jumping 5.15% to $37.36 on Tuesday while NASDAQ Composite jumped 0.77% to $15,975.21.
Volume
Today’s last reported volume for Arcturus Therapeutics is 401433, 19.26% below its average volume of 497252.
Arcturus Therapeutics’s last close was $35.53, 72.61% under its 52-week high of $129.71.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the present quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $37.36 at 16:06 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is way under its 50-day moving average of $44.81 and below its 200-day moving average of $40.32.
More news about Arcturus Therapeutics (ARCT).
